Investigación local. Conexiones humanas. WCR Miami Lakes (786) 483-7856
Volver a buscar estudiosNCT06842446
ReclutandoNCT06842446Registro de ClinicalTrials.gov

Systematic Machine Learning Algorithm for Rapid Thrombosis Detection

Deep Vein Thrombosis

LO ESENCIAL

De qué trata este estudio

El registro indica que este estudio recluta participantes. La disponibilidad puede variar por centro.

Tipo de estudio
De intervención
Fase
No aplica
Rango de edad
18 años - No especificado
Sexo admitido
Todos los sexos
Voluntarios sanos
No aceptados
Participantes
1000 Estimado

Estos son puntos de partida, no una decisión de elegibilidad. El equipo debe revisar todos los requisitos.

Las explicaciones y la navegación están en español. Los textos proporcionados por el registro, incluidos títulos, resúmenes y criterios, se conservan en su idioma original. Puedes pedir orientación en español a WCR.

Acerca de la investigación

The goal of this clinical trial is to compare the use of a machine learning-based algorithm and point-of-care D-dimer to laboratory D-dimer and compression ultrasound to exclude deep vein thrombosis in the under extremities in patients referred to a medical department suspected of having deep vein thrombosis. The main aim is to answer are if a machine learning algorithm and point of care D-dimer can exclude deep vein thrombosis in more patients than clinical assessment and D-dimer alone.

Leer la descripción completa

All participants will follow the usual diagnostic algorithm used for patients with suspected DVT referred to Ostfold Hospital (all patients are examined by a physician, D-dimer is analyzed in all patients, ultrasound is performed by a radiologist in patients with positive D-dimer). In addition to usual care, POC D-dimer, POC ultrasound (performed by ED physicians), blood sampling for biobanking, and photographies of the under extremities will be performed. The machine learning model will be tested to see if the prediction is correct. In participants where ultrasound is performed, it will also be assessed whether the machine learning algorithm could have excluded the participant without the use of ultrasound. None of the additional procedures will have any impact on the patient diagnostics or treatment.

¿Quién podría participar?

La lista siguiente contiene el texto del patrocinador. Puede incluir condiciones, tratamientos previos, resultados de pruebas y otros requisitos. Aparecer en tu búsqueda no significa que califiques.

Inclusion Criteria:

  • Patients referred to the ED due to suspicion of DVT
  • Age ≥ 18 years
  • Able to give informed consent

Exclusion Criteria:

  • Ongoing use of anticoagulation for more than 72 hours
  • Previous participation in the study
  • Life expectancy of less than three months.
Entiende la evaluación inicial

Tratamiento, grupos y participación

El registro puede describir tratamientos y duración sin incluir un calendario completo. Pide al equipo las visitas, procedimientos, riesgos, costos y alternativas. Mantén tu atención habitual salvo que tu médico te indique un cambio.

Asignación
No aplica
Enmascaramiento
Sin enmascaramiento
All participants

All participants will be treated the same way.

Diagnostic Test: POC D-dimer · Diagnostic Test: POC ultrasound · Diagnostic Test: Machine learning model

POC D-dimer DIAGNOSTIC_TEST

POC D-dimer will be compared to laboratory D-dimer in hospital setting and used in a machine learning model

POC ultrasound DIAGNOSTIC_TEST

Point of care (POC) ultrasound performed by ED physicians compared to ultrasound performed by radiologist. POC ultrasound 3 point examination performed by ED physician will be compared with POC ultrasound full leg examination performed by ED physician.

Machine learning model DIAGNOSTIC_TEST

The DSS will be compared to the usual strategy. It will also be estimated how many participants where DVT could have been excluded without ultrasound.

Prepara tus preguntas

Qué evalúan los investigadores

Estas medidas indican qué se estudia. No prueban que un tratamiento funcione.

Medidas principales

Safety of the new strategy (POC D-dimer, ML-based prediction model, POC CUS by emergency physician)

Plazo: From enrollment to the end of the primary assessment period (90 days)

Evaluate the safety of a new strategy consisting of POC D-dimer and an ML-based prediction model followed by CUS performed by emergency physicians by comparing the new strategy's safety with our standard care by measuring the proportion of patients in whom DVT is excluded according to the new strategy but was diagnosed with DVT by standard care or in whom DVT is diagnosed within the 90-day follow up.

Medidas secundarias

Evaluate the efficiency of the new strategy

Plazo: From enrollment to the end of the primary assessment period (90 days)

The proportion of patients in whom DVT can be ruled out by the ML-based prediction model with POC D-dimer compared to the efficiency of Wells score and laboratory D-dimer

Validate the safety and efficiency of the ML-based prediction model

Plazo: From enrollment to the end of the primary assessment period (90 days)

Safety will be determined by the proportion of patients in whom DVT is excluded by the ML-model but diagnosed by standard care. Efficiency will be determined by the proportion of patients in whom DVT can be excluded by the ML-based model

Evaluate concordance between CUS performed by emergency physicians and radiologists.

Plazo: From time of enrollment until time of ultrasound examination performed by radiologist, assessed up to 48 hours.

Determine the proportion of false negative and false positive diagnosis of DVT in emergency physician-performed ultrasound compared with ultrasound performed by radiologists.

Evaluate concordance between POC D-dimers in an ED setting and laboratory D-dimers.

Plazo: From enrollment to the completion of D-dimer analysis, assessed up to 24 hours.

Compare the two POC D-dimers with the STA-Liatest D-dimer and Siemens INNOVANCE by direct comparison of the true/false positive/negative results.

Evaluate the hypothetical time to be completed for the novel strategy compared to the standard strategy.

Plazo: From time of enrollment until time of discharge from the emergency department either discharged from the hospital or hospitalized, assessed up to 24 hours.

Estimating the total management time defined as time from ED registration to ED discharge in patients evaluated according to the new strategy compared to standard care.

Evaluate the safety of a limited ultrasound protocol (two-point and proximal) compared to full-leg CUS performed by emergency physicians and radiologists

Plazo: 90 days after enrollment.

Estimating the proportion of patients in whom DVT was ruled out by the limited ultrasound protocol but was diagnosed with DVT by the whole-leg ultrasound.

El registro no indica resultados publicados.

Revisa las tablas completas y sus limitaciones en el registro oficial.

Abrir resultados oficiales ↗

Centros de investigación (1)

El estado general puede diferir del estado de un centro. Confirma la disponibilidad antes de trasladarte.

1 centros

Østfold Hospital TrustSarpsborg, NorwayReclutando
Hans J Myklebust-Hansen, M.D.CONTACThansjoakim_mh@outlook.com004797501765
Hans J Myklebust-Hansen, M.D.SUB_INVESTIGATOR
Ver ubicación en el mapa ↗

Equipo y fechas

Patrocinador principal
Ostfold Hospital Trust
Inicio del estudio
6 ene 2025 Real
Finalización primaria
5 abr 2027 Estimado
Finalización del estudio
5 abr 2029 Estimado
Primera publicación
24 feb 2025 Real
Última actualización
10 nov 2026 Real

Contactos oficiales del estudio

Waleed Ghanima, ProfessorCONTACTwaleed.ghanima@so-hf.no69860000 0047
Hans Joakim Myklebust-Hansen, Medical DoctorCONTACThans.joakim.hansen@so-hf.no97501765 0047
Título oficial del estudio

Evaluating a New Diagnostic Strategy for Suspected DVT Consisting of Point of Care D-dimer, AI-based Prediction Model and Compression Ultrasound

EL PRÓXIMO PASO, CON APOYO HUMANO

Consulta a Wellness Clinical Research

Tu mensaje va a WCR, incluso si otra organización realiza este estudio. WCR puede orientarte, pero podría no realizar este estudio, tener acceso a su equipo ni poder inscribirte.

No incluyas expedientes médicos, diagnósticos, medicamentos, números de seguro ni otros datos sensibles. Este formulario es para preguntas generales, no para atención urgente.

Enviar una pregunta no te inscribe en un estudio.

Fuente: API v2 de ClinicalTrials.gov. Patrocinadores e investigadores envían la información. La NLM no aprueba la seguridad ni la ciencia de todos los estudios registrados. Aviso del registro.

Consultado: 12 nov 2026 · Última actualización del registro: 10 nov 2026